Dr. Hormoz Kianfar, MD

Dr. Kianfar practices at Ocean Heart Group, Limited Liability Company in Brick, New Jersey.

Dr. Kianfar's NPI, 1306008727, was assigned on June 26, 2008. Dr. Kianfar holds New Jersey license 25MA09562700.

Dr. Kianfar's primary practice is Ocean Heart Group, Limited Liability Company, at 1530 State Highway 88, Brick, NJ 08724 in Ocean County. The practice phone is (917) 254-8933.

Dr. Kianfar's primary practice is Ocean Heart Group, Limited Liability Company in Brick, New Jersey. Dr. Kianfar is also affiliated with Ocean University Medical Center. The medical group on file is Meridian Cardiovascular Interpretive Services. Dmand AI also links Dr. Kianfar to 4 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kianfar practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kianfar's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Kianfar's licenses on file in 2 states: New Jersey and New York.

CMS data shows 6,858 Medicare services from Dr. Kianfar across 23 procedure codes in 2024, for 1,404 Medicare patients. Medicare paid $393,734 for them.

CMS counts 1,404 Medicare patients who saw Dr. Kianfar in 2024. The largest group is 65 to 74, with 509 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kianfar's median patient age at 70, with 51% women.

In 2024, Dr. Kianfar wrote 10,220 Medicare Part D claims for 1,501 patients. 84% of them were for generic drugs. CMS names the drug for 9,807 of them, across 97 drugs with 11 or more claims each, at $1,893,314 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kianfar for performance year 2024, reported as part of a group. Dr. Kianfar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kianfar as offering telehealth. CMS counts 33 procedures of leg revascularization (restoring blood flow) by Dr. Kianfar, more than 90% of the clinicians it reports for that procedure.

CMS Open Payments shows 366 general payments to Dr. Kianfar from 34 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 80% of the total. Medtronic, Inc. paid the most, $3,132.